A Trial of RLX-2508-102 in Healthy Volunteers

StatusNot Yet Recruiting
PhaseEarly Phase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this study is to assess safety, PK and immunogenicity profile of a single dose and multiple dose of RLX-2508 in healthy participants across different ethnic backgrounds.
Trial Details
NCT Number NCT07873671
Lead Sponsor Atridia Pty Ltd.
Conditions
(from sponsor)		 Influenza
Related terms Influenza, Human
Enrollment 101 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov